HomeVERV • NASDAQ
add
Verve Therapeutics Inc
Previous close
$6.33
Day range
$6.04 - $6.43
Year range
$4.31 - $16.43
Market cap
522.38M USD
Avg Volume
1.61M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 13.08M | 154.28% |
Operating expense | 195.60M | 9.82% |
Net income | -50.04M | -3.48% |
Net profit margin | -382.53 | 59.30% |
Earnings per share | -0.58 | 15.94% |
EBITDA | -54.37M | -3.69% |
Effective tax rate | -0.15% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 524.28M | -15.97% |
Total assets | 647.39M | -13.99% |
Total liabilities | 153.99M | 0.53% |
Total equity | 493.40M | — |
Shares outstanding | 88.80M | — |
Price to book | 1.14 | — |
Return on assets | -21.38% | — |
Return on capital | -24.52% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -50.04M | -3.48% |
Cash from operations | -40.84M | -0.41% |
Cash from investing | 29.55M | 432.24% |
Cash from financing | 25.15M | -85.82% |
Net change in cash | 13.85M | -89.16% |
Free cash flow | -26.02M | -9.60% |
About
Founded
2018
Headquarters
Website
Employees
274
